Article
Atlanta -- The so-called mystery rash is getting more mysterious. In fact, the Centers for Disease Control and Prevention says the hubbub played up in local and national media might be unfounded.
Dupilumab Reduces Levels of Immunoglobulin E in Pediatric Patients with Moderate-to-Severe AD
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Understanding and Treating Pediatric AD Inside and Out
The Cutaneous Connection: Episode 28- The Path to Understanding Pediatric Melanoma
Reviewing Complex Cases: Topicals for Pediatric AD
Study Finds Propranolol Initiation for Infantile Hemangiomas Safe with Less Monitoring